Wells Fargo & Company Immunocore Holdings PLC Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Wells Fargo & Company holds 86,096 shares of IMCR stock, worth $3.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,096
Previous 84,143
2.32%
Holding current value
$3.42 Million
Previous $5.75 Million
2.64%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IMCR
# of Institutions
161Shares Held
37.7MCall Options Held
540KPut Options Held
97.3K-
Rtw Investments, LP New York, NY6.02MShares$239 Million6.28% of portfolio
-
Wellington Management Group LLP Boston, MA5.75MShares$228 Million0.07% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.44MShares$96.9 Million0.02% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.37MShares$94.1 Million4.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY1.79MShares$71 Million4.36% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.74B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...